MODULE 3 MEDICATIONS Flashcards
CLASSIFICATION
ADENOSINE
- ANTIDYSRHYTHMIC AGENT
DOSAGE
ADULT
ADENOSINE
- FIRST DOSE: 6 MG RAPID IV/IO
- SECOND DOSE: 12 MG RAPID IV/IO
DOSAGE
PEDIATRIC
ADENOSINE
- FIRST DOSE: 0.1MG/KG IV/IO MAX 6MG
- SECOND DOSE: 0.2MG/KG MAX 12MG
INDICATION
ADENOSINE
- SVT/PSVT
- WIDE COMPLEX - REGULAR TACHYCARDIA OF UNKNOWN ORIGIN (DIAGNOSTIC TREATMENT)
CONTRAINDICATION
ADENOSINE
- CONFIRMED V-TACH, A-FIB, A-FLUTTER
- KNOWN HYPERSENSITIVITY
- WPW
ADVERSE EFFECTS
ADENOSINE
- FEELING OF IMPENDING DOOM
- SHORTNESS OF BREATH
- CHEST PRESSURE
- HYPOTENSION
- FLUSHING
- DIZZINESSS
- NAUSEA
- HEADACHE
CLASSIFICATION
AMIODARONE
- ANTIARRHYTHMIC
DOSAGE
V-FIB/PULSELESS VT
AMIODARONE
- FIRST DOSE: 300MG IV/IO (DILUTED IN 20-30ML D5W)
- SECOND DOSE: 150MG (DILUTED IN 20-30ML D5W)
- MAX TOTAL BOLUS 450M
DOSAGE
WIDE COMPLEX TACHYCARDIA W/PULSE
AMIODARONE
- 150MG IV/IO DILUTED IN 50-100ML OVER 10 MIN
DOSAGE
MAINTANANCE INFUSION
AMIODARONE
- 1MG/MIN
- 100MG IN 100ML D5W
INDICATION
AMIODARONE
- V-TACH (WITH & WITHOUT PULSE)
- V-FIB
- REFRACTORY V-TACH
CONTRAINDICATION
AMIODARONE
- CARDIOGENIC SHOCK
- HIGH DEGREE HEART BLOCK (2 MOBITZ II & 3)
- IODINE ALLERGY
- NONE IN CARDIAC ARREST
- SA NODE DISFUCTIONS
ADVERSE EFFECTS
AMIODARONE
- BRADYCARDIA
- CONGESTIVE HEART FAILURE
- HYPOTENSION
- NAUSEA
- VOMITING
CLASSIFICATION
ATROPINE
- PARASYMPATHOLYTIC
- ANTICHOLINERGIC
DOSAGE
ADULT BRADYCARDIA
ATROPINE
- 1MG IV/IO/ET
- EVERY 3-5MIN
- MAX DOSE OF 3MG
DOSAGE
PEDIATRIC BRADYCARDIA
ATROPINE
- 0.02 MG/KG IV/IO/ET
- MINIMUM DOSE 0.1MG
DOSAGE
ADULT ORGANOPHOSPHATE POISONING
ATROPINE
- 1-4MG IV/IO/ET/IM
- EVERY 5-10 UNTIL ATROPINIZATION OCCURS
INDICATION
ATROPINE
- SYMPTOMATIC BRADYCARDIA
- ORGANOPHOSPHATE POISONING
- NERVE AGENT POISONING
CONTRAINDICATION
ATROPINE
- DYSRHYTHMIAS THAT ACCELERATE VENTRICULAR RATE AND DECREASE CARDIAC OUTPUT
- EXAMPLES: A-FIB, A-FLUTTER, PAT W/ BLOCK
ADVERSE EFFECTS
ATROPINE
- ATAXIA
- BLURRED VISION
- COMA
- DELERIUM
- DISORIENTATION
- RESTLESSNESS
- TACHYCARDIA
CLASSIFICATION
DILTAZEM (CARDIZEM)
- CALCIUM CHANNEL BLOCKER
- ANTIDYSRHYTHMIC
DOSAGE
DILTAZEM (CARDIZEM)
- INITAL: 0.25MG/KG IV/IO OVER 5MIN (MAX 20MG)
- REPEAT IN 15MIN: O.35MG/KG IV/IO OVER 5MIN (MAX 25MG)
- MAINTENANCE INFUSION: 5-15MG/HR
INDICATION
DILTAZEM (CARDIZEM)
- STABLE UNCONTROLLED A-FIB/A-FLUTTER WITH SUSTAINED RATES >120BPM
- SECOND LINE MEDICATION FOR STABLE REGULAR-NARROW COMPLEX TACHYDYSRHTHMIAS (SVT/PSVT)
CONTRAINDICATION
DILTAZEM (CARDIZEM)
- HEART FAILURE
- HIGH DEGREE HEART BLOCK (2nd DEGREE: II or 3rd DEGREE)
- HYPOTENSION
- SHOCK
- V-TACH
ADVERSE EFFECTS
DILTAZEM (CARDIZEM)
- DYSRHTHMIAS
- HEADACHES
- HYPOTENSION
- NAUSEA
- VOMITING
CLASSIFICATION
DOPAMINE
- INOTROPIC AGENT
- SYMPATHOMIMETIC
- VASOPRESSOR
DOSAGE
ADULT
DOPAMINE
- 5-20 MCG/KG/MIN IV DRIP TITRATED TO SYSTOLIC BP OF 0F 90
- INITIAL DOSE OF 5MCG/KG/MIN
DOSAGE
PEDIATRIC
DOPAMINE
- 2-20 MCG/KG/MIN IV DRIP TITRATED TO AGE SPECIFIC SYSTOLIC BP
- INITIAL RATE OF 2 MCG/KG/MIN
INDICATION
DOPAMINE
- CARDIOGENIC SHOCK
- SHOCK (ALL ETIOLOGIES)
- SYMPTOMATIC BRADYCARDIA (AFTER ATROPINE ADMINISTRATION)
CONTRAINDICATION
DOPAMINE
- PRE-EXISTING TACHYDYSRHTHMIAS
- UNCORRECTED HYPOVOLEMIA
ADVERSE EFFECTS
DOPAMINE
- ANGINAL PAIN
- HYPERTENSION
- TACHYDYSRHTHMIAS
- NAUSEA
- VOMMITING
CLASSIFICATION
LIDOCANE
- ANTIDYSRHTMIC
- SODIUM CHANNEL BLOCKER
DOSAGE
ADULT VT W/PULSE
LIDOCANE
- 0.5 -1.5 MG/KG IV/IO MAX 3MG/KG
- REPEAT DOSES ARE HALF OF INITIAL DOSE
DOASGE
ADULT VT/VF W/O PULSE
LIDOCANE
- 1-1.5 MG/KG IV/IO BOLUS
- REPEAT EVERY 5-10MIN
- MAX 3MG/KG
- REPEAT DOSES ARE HALF OF INITIAL DOSE
DOSAGE
PEDIATRIC VT WITH/WITHOUT PULSE
LIDOCANE
- 1MG/KG IV/IO
- EVERY 5-10MIN
- MAX 3MG/KG
DOSAGE
ADULT IO ADMIN FOR NUMBING
LIDOCANE
- 20 - 40 MG SLOW IO PUSH
INDICATION
LIDOCANE
- V-TACH WITH/WITHOUT PULSLE
- V-FIB
- IO NUMBING
- DECREASE INTREACRANIAL PRESSURE WITH RSI
- REDUCE ERADIC VENTRICULAR ECTOPY
CONTRAINDICATION
LIDOCANE
- ACCELERATED IDIOVENTRICULAR RHYTHMS
- AV BLOCK
- IDIOVENTRICULAR ESCAPE RHYTHEMS
- SINUS- BRADY/ARREST/BLOCK
- STOKE-ADAM SYNDROME
- WOLFF-PARKINSON-WHITE (WPW)
ADVERSE EFFECTS
(TOXICITY)
LIDOCANE
- MAY CAUSE CLINICAL EVIDENCE OF TOXICITY
- EARLY SIGNS:
- ALTERED MENTAL STATUS
- ANXIETY
- BRADYCARDIA
- TROUBLE BREATHING
- NAUSEA
- LATE SIGNS:
- COMA
- WIDENING OF QRS COMPLEX
- HALLUCINATIONS
- HEARING LOSS
- PROLONGED P-R INTERVAL
CLASSIFICATION
METOPROLOL
- BETA BLOCKER
DOSAGE
METOPROLOL
- 5MG IVP OVER 5MIN
- REPEAT EVERY 5
INDICATION
METOPROLOL
- A-FIB/A-FLUTTER WITH SUSTAINED RATE OVER 120BPM
- ACUTE CORONARY SYNDROME ASSOCIATED W/STEMI TACHYCARDIA
- REFRACTORY PSVT/SVT
CONTRAINDICATION
METOPROLOL
- ASTHMA ATTACK OR COPD EXACERBATION
- SYSTOLIC LESS THAN 90
- HR LESS THAN 100
- HIGH DEGREE HEART BLOCK (2ND OR 3RD DEGREE AV BLOCK)
- SHOCK
ADVERSE EFFECTS
METOPROLOL
- CHF
- CNS CHANGES
- DYSRYTHMIAS
- HYPOTENSION
- NAUSEA
- VOMITING
CLASSIFICATION
VERAPAMIL
- CALCIUM CHANNEL BLOCKER
- ANTIDYSRHYTHMIC
DOSAGE
VERAPAMIL
- INITIAL: 2.5-5MG IV/IO OVER 2 MIN
- REPEAT: 5-10MG IN 15-30MIN
- MAX OF 20MG
INDICATION
VERAPAMIL
- STABLE UNCONTROLLED A-FLUTTER OR FIBRILATION WITH RVR
- SECOND LINE MEDICATION FOR STABLE NARROW COMPLEX TACHYDYSRHYTHMIAS (PSVT/SVT)
CONTRAINDICATION
VERAPAMIL
- HEART FAILURE
- HIGH DEGREE HEART BLOCK
- HYPERSENSITIVITY
- V-TACH
- SHOCK
- WPW
- SICK SINUS SYNDROME
ADVERSE EFFECTS
VERAPAMIL
- HEADACHES
- HYPOTENSION
- DYSRHYTHMIAS
- NAUSEA
CLASSIFICATION
EPINEPHRINE
- ADRENERGIC CATECHOLAMINE
- SYMPATHOMIMETIC (VASOPRESSOR)
DOSAGE
ADULT CARDIAC ARREST
EPINEPHRINE
- 1MG (1:10,000) IV/IO
- EVERY 3-5MIN
DOSAGE
PEDIATRIC CARDIAC ARREST
EPINEPHRINE
- 0.01MG/KG (1:10,000) IV/IO EVERY 3-5MIN
DOSAGE
ROSC
EPINEPHREN
- 0.1 - 0.5 MCG/KG/MIN
- STANDARD CONCENTRATION = 1MG EPI/250ML NS
DOSAGE
SYMPTOMATIC (UNSTABLE) BRADYCARDIA ADULT
EPINEPHREN
- 2-10 MCG/MIN
- 1MG EPI IN 250ML D5W
DOSAGE
SYMPTOMATIC (UNSTABLE) BRADYCARDIA PEDIATRIC
EPINEPHREN
- 0.01MG/KG (1:10,000) IV/IO
- REPEAT EVERY 3-5MIN
INDICATION
EPINEPHRINE
- CARDIAC ARREST
- ROSC
- SYMPTOMATIC BRADYCARDIA
- ANAPHYLAXIS
- BRONCHIAL ASTHMA
- STRIDOR
CONTRAINDICATION
EPINEPHRINE
- HYPERTENSION
- NONE IN CARDIAC SETTING
ADVERSE EFFECTS
EPINEPHRINE
- TACHYDYSRHYTHMIAS
- HYPERTENSION
- HEADACHE
- TREMORS
- NERVOUSNESS
- REBOUND EDEMA
- MAY INDUCE EARLY LABOR IN PREGNANT WOMEN
